Rosenthal DL, Vandenbussche CJ, Burroughs FH, Sathiyamoorthy S, Guan H, Owens C. The Johns Hopkins Hospital template for urologic cytology samples: part I-creating the template. Cancer Cytopathol. 2013;121:15–20.
Wojcik EM. What should not be reported as atypia in urine cytology. J Am Soc Cytopathol. 2015;4:30–6.
Harris MJ, Schwinn CP, Morrow JW, Gray RL, Browell BM. Exfoliative cytology of the urinary bladder irrigation specimen. Acta Cytol. 1971;15:385–99.
Hughes JH, Raab SS, Cohen MB. The cytologic diagnosis of low-grade transitional cell carcinoma. Am J Clin Pathol. 2000;114(Suppl):59.
Raab SS, Slagel DD, Jensen CS, Teague MW, Savell VH, Ozkutlu D, Lenel JC, Cohen MB. Low-grade transitional cell carcinoma of the urinary bladder: application of select cytologic criteria to improve diagnostic accuracy [corrected]. Mod Pathol. 1996;9:225–32.
Raab SS, Lenel JC, Cohen MB. Low grade transitional cell carcinoma of the bladder. Cytologic diagnosis by key features as identified by logistic regression analysis. Cancer. 1994;74:1621–6.
Barkan GA, Wojcik EM. Genitourinary cytopathology (kidney and urinary tract). Cancer Treat Res. 2014;160:149–83.
Wojcik EM, Brownlie RJ, Bassler TJ, Miller MC. Superficial urothelial (umbrella) cells. A potential cause of abnormal DNA ploidy results in urine specimens. Anal Quant Cytol Histol. 2000;22:411–5.
Zhou AG, Hutchinson LM, Cosar EF. Urine cytopathology and ancillary methods. Surg Pathol Clin. 2014;7(1):77–88.
Reynolds JP, Voss JS, Kipp BR, Karnes RJ, Nassar A, Clayton AC, Henry MR, Sebo TJ, Zhang J, Halling KC. Comparison of urine cytology and fluorescence in situ hybridization in upper urothelial tract samples. Cancer Cytopathol. 2014;122:459–67.
Tapia C, Glatz K, Obermann EC, Grilli B, Barascud A, Herzog M, Schonegg R, Savic S, Bubendorf L. Evaluation of chromosomal aberrations in patients with benign conditions and reactive changes in urinary cytology. Cancer Cytopathol. 2011;119(6):404–10.
Bullock PS, Thoni DE, Murphy WM. The significance of colonic mucosa (intestinal metaplasia) involving the urinary tract. Cancer. 1987;59(12):2086–90.
Cowan ML, Rosenthal DL, VandenBussche CJ. Improved risk stratification for patients with high-grade urothelial carcinoma following application of the Paris System for Reporting Urinary Cytology. Cancer Cytopathol. 2017;125(6):427–34.
Frost JK. Concepts basic to general cytopathology. 4th ed. Baltimore: The Johns Hopkins Press; 1972.
Layfield LJ, Elsheikh TM, Fili A, Nayar R, Shidham V. Papanicolaou Society of Cytopathology: review of the state of the art and recommendations of the Papanicolaou Society of Cytopathology for urinary cytology procedures and reporting : the Papanicolaou Society of Cytopathology Practice Guidelines Task Force. Diagn Cytopathol. 2004;30(1):24–30.
Renshaw AA. Compassionate conservatism in urinary cytology. Diagn Cytopathol. 2000;22(3):137–8.
Renshaw AA, Nappi D, Weinberg DS. Cytology of grade 1 papillary transitional cell carcinoma. A comparison of cytologic, architectural and morphometric criteria in cystoscopically obtained urine. Acta Cytol. 1996;40(4):676–82.
Zhang ML, Rosenthal DL, VandenBussche CJ. The cytomorphological features of low-grade urothelial neoplasms vary by specimen type. Cancer Cytopathol. 2016;124(8):552–64.
Onur I, Rosenthal DL, VandenBussche CJ. Benign-appearing urothelial tissue fragments in noninstrumented voided urine specimens are associated with low rates of urothelial neoplasia. Cancer Cytopathol. 2015;123(3):180–5.
Onur I, Rosenthal DL, VandenBussche CJ. Atypical urothelial tissue fragments in noninstrumented voided urine specimens are associated with low but significantly higher rates of urothelial neoplasia than benign-appearing urothelial tissue fragments. Cancer Cytopathol. 2015;123(3):186–92.
McCroskey Z, Kliethermes S, Bahar B, Barkan GA, Pambuccian SE, Wojcik EM. Is a consistent cytologic diagnosis of low-grade urothelial carcinoma in instrumented urinary tract cytologic specimens possible? A comparison between cytomorphologic features of low-grade urothelial carcinoma and non-neoplastic changes shows extensive overlap, making a reliable diagnosis impossible. J Am Soc Cytopathol. 2015;4(2):90–7.
Zhang ML, Zhou AG, Rosenthal DL, VandenBussche CJ. Urinary tract washing specimens containing atypical urothelial tissue fragments are significantly associated with urothelial neoplasia. Diagn Cytopathol. 2017;45(9):795–9.
Blacher EJ. Squamous cell carcinoma of renal pelvis. Urology. 1985:124–6.
Li MK, Cheung WL. Squamous cell carcinoma of the renal pelvis. J Urol. 1987;138(2):269–71.
Pinto M, Dobson S. BK and JC virus: a review. J Infect. 2014;68(Suppl 1):2.
Paquette C, Elhosseiny A. Significance of polyomavirus detection in urine cytology: an update. Diagn Histopathol. 2012;18:321–6.
Koss LG. On decoy cells. Acta Cytol. 2005;49:233–4.
Wojcik EM, Miller MC, Wright BC, Veltri RW, O’Dowd GJ. Comparative analysis of DNA content in polyomavirus-infected urothelial cells, urothelial dysplasia and high grade transitional cell carcinoma. Anal Quant Cytol Histol. 1997;19:430–6.
Bakhos R, Shankey TV, Flanigan RC, Fisher S, Wojcik EM. Comparative analysis of DNA flow cytometry and cytology of bladder washings: review of discordant cases. Diagn Cytopathol. 2000;22:65–9.
Halling KC, Kipp BR. Bladder cancer detection using FISH (UroVysion assay). Adv Anat Pathol. 2008;15:279–86.
Galed-Placed I, Valbuena-Ruvira L. Decoy cells and malignant cells coexisting in the urine from a transplant recipient with BK virus nephropathy and bladder adenocarcinoma. Diagn Cytopathol. 2011;39:933–7.
Geetha D, Tong BC, Racusen L, Markowitz JS, Westra WH. Bladder carcinoma in a transplant recipient: evidence to implicate the BK human polyomavirus as a causal transforming agent. Transplantation. 2002;73(12):1933–6.
Lu H, Elsheikh TM, Zhang Y. Polyomavirus (BK) cytopathic effect in urine cytology is not associated with high risk of developing high-grade urothelial carcinoma. J Am Soc Cytopathol. 2020;9(2):84–8.
Allison DB, Olson MT, Lilo M, Zhang ML, Rosenthal DL, VandenBussche CJ. Should the BK polyomavirus cytopathic effect be best classified as atypical or benign in urine cytology specimens? Cancer Cytopathol. 2016;124(6):436–42.
Martinez-Giron R, Esteban-Sanchis JG. Parasite eggs in urine cytology: fact or artifact? Diagn Cytopathol. 2009;37(5):353–4.
Talar-Williams C, Hijazi YM, Walther MM, Linehan WM, Hallahan CW, Lubensky I, Kerr GS, Hoffman GS, Fauci AS, Sneller MC. Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis. Ann Intern Med. 1996;124(5):477–84.
Knight A, Askling J, Granath F, Sparen P, Ekbom A. Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide. Ann Rheum Dis. 2004;63(10):1307–11.
Pierconti F, Rossi ED, Straccia P, Fadda G, Larocca LM, Bassi PF, Sacco E, Schinzari G. The risk of malignancy of atypical urothelial cells of undetermined significance in patients treated with chemohyperthermia or electromotive drug administration. Cancer Cytopathol. 2018;126(3):200–6.
Garret M, Hamm FC. Atypical cells of origin from the seminal vesicles, complicating cytologic evaluation of prostatic secretions. Am J Clin Pathol. 1963;39:265–72.
Terada T. Monstrous epithelial cell clusters in the seminal vesicle. Int J Clin Exp Pathol. 2011;4(7):727–30.
Wojcik EM, Bassler TJ, Orozco R. DNA ploidy in seminal vesicle cells. A potential diagnostic pitfall in urine cytology. Anal Quant Cytol Histol. 1999;21(1):29–34.
Cimino-Mathews A, Ali SZ. The clinicopathologic correlates of cellular atypia in urinary cytology of ileal neobladders. Acta Cytol. 2011;55(5):449–54.
Nomani L, Abro S, Quek ML, Barkan GA. Guar bean in urinary cytology: a morphologic pitfall. J Am Soc Cytopathol. 2021;10(1):41–6.
Ali-El-Dein B, El-Tabey N, Abdel-Latif M, Abdel-Rahim M, El-Bahnasawy M. Late uro-ileal cancer after incorporation of ileum into the urinary tract. J Urol. 2002;167:84–8.
Brimo F, Vollmer RT, Case B, Aprikian A, Kassouf W, Auger M. Accuracy of urine cytology and the significance of an atypical category. Am J Clin Pathol. 2009;132:785–93.
Raab SS, Grzybicki DM, Vrbin CM, Geisinger KR. Urine cytology discrepancies: frequency, causes, and outcomes. Am J Clin Pathol. 2007;127:946–53.
McIntire PJ, Khan R, Hussain H, Pambuccian SE, Wojcik EM, Barkan GA. Negative predictive value and sensitivity of urine cytology prior to implementation of The Paris System for Reporting Urinary Cytology. Cancer Cytopathol. 2019;127(2):125–31.
McIntire PJ, Kilic I, Pambuccian SE, Wojcik EM, Barkan GA. The Paris System for Reporting Urinary Cytology reduces atypia rates and does not alter the negative predictive value of urine cytology. J Am Soc Cytopathol. 2021;10(1):14–9.
Ajit D, Dighe SB, Desai SB. Cytology of lleal conduit urine in bladder cancer patients: diagnostic utility and pitfalls. Acta Cytol. 2006;50:70–3.
Cimino-Mathews A, Ali SZ. The clinicopathologic correlates of cellular atypia in urinary cytology of ileal neobladders. Acta Cytol. 2011;55:449–54.